ARTELO BIOSCIENCES, INC. Quarterly Return On Equity in % from Q4 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Artelo Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2015 to Q3 2024.
  • Artelo Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -104 %, a 85.4% decline year-over-year.
  • Artelo Biosciences, Inc. annual Return On Equity for 2023 was -61.7 %, a 39.1% decline from 2022.
  • Artelo Biosciences, Inc. annual Return On Equity for 2022 was -44.4 %, a 23.6% increase from 2021.
  • Artelo Biosciences, Inc. annual Return On Equity for 2021 was -58.1 %, a 50.8% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -104 -48.1 -85.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -96.7 -46.5 -92.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -73.7 -24 -48.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -61.7 -17.3 -39.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -56.3 -12.6 -28.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -50.2 -1.72 -3.55% Apr 1, 2023 Jun 30, 2023
Q1 2023 -49.7 +4.64 +8.54% Jan 1, 2023 Mar 31, 2023
Q4 2022 -44.4 +18.8 +29.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -43.7 +28 +39.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.5 +24.8 +33.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -54.3 +25.3 +31.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -63.2 +49.4 +43.9% Sep 1, 2021 Dec 31, 2021
Q3 2021 -71.7 +46.3 +39.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -73.3 +29.8 +28.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -79.6 +28.8 +26.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -113 +5.93 +5.01% Sep 1, 2020 Dec 31, 2020
Q3 2020 -118 +78.2 +39.8% Jun 1, 2020 Aug 31, 2020
Q2 2020 -103 -794 -115% Mar 1, 2020 May 31, 2020
Q1 2020 -108 -754 -117% Dec 1, 2019 Feb 29, 2020
Q4 2019 -118 -2.28K -105% Sep 1, 2019 Nov 30, 2019
Q3 2019 -196 +3.12K +94.1% Jun 1, 2019 Aug 31, 2019
Q2 2019 691 +1.43K Mar 1, 2019 May 31, 2019
Q1 2019 646 +1.19K Dec 1, 2018 Feb 28, 2019
Q4 2018 2.16K +2.44K Sep 1, 2018 Nov 30, 2018
Q3 2018 -3.31K -3.08K -1328% Jun 1, 2018 Aug 31, 2018
Q2 2018 -735 -1.06K -329% Mar 1, 2018 May 31, 2018
Q1 2018 -548 -807 -311% Dec 1, 2017 Feb 28, 2018
Q4 2017 -285 -566 -201% Sep 1, 2017 Nov 30, 2017
Q3 2017 -232 -672 -153% Jun 1, 2017 Aug 31, 2017
Q2 2017 321 +4.8K Mar 1, 2017 May 31, 2017
Q1 2017 259 +703 Dec 1, 2016 Feb 28, 2017
Q4 2016 281 +600 Sep 1, 2016 Nov 30, 2016
Q3 2016 440 Jun 1, 2016 Aug 31, 2016
Q2 2016 -4.48K Mar 1, 2016 May 31, 2016
Q1 2016 -443 Dec 1, 2015 Feb 29, 2016
Q4 2015 -319 Sep 1, 2015 Nov 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.